Canada Life’s PTC Therapeutics PTCT Stock Holding History

Canada Life’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.22M	Sell	64,112 -1,266	-2%	-$91.4K	0.01%	770
2026 Q1	$4.45M	Sell	65,378 -12,772	-16%	-$904K	0.01%	795
2025 Q4	$5.94M	Buy	78,150 +44,166	+130%	+$3.21M	0.01%	684
2025 Q3	$2.06M	Buy	33,984 +12,191	+56%	+$635K	﹤0.01%	1213
2025 Q2	$1.06M	Buy	21,793 +1,755	+9%	+$83.3K	﹤0.01%	1411
2025 Q1	$1.02M	Hold	20,038	–	–	﹤0.01%	1431
2024 Q4	$904K	Hold	20,038	–	–	﹤0.01%	1502
2024 Q3	$745K	Hold	20,038	–	–	﹤0.01%	1589
2024 Q2	$612K	Sell	20,038 -6,327	-24%	-$205K	﹤0.01%	1631
2024 Q1	$767K	Sell	26,365 -2,812	-10%	-$78.8K	﹤0.01%	1566
2023 Q4	$799K	Buy	29,177 +4,175	+17%	+$95.5K	﹤0.01%	1575
2023 Q3	$560K	Buy	25,002 +3,300	+15%	+$123K	﹤0.01%	1658
2023 Q2	$889K	Buy	21,702 +2,552	+13%	+$125K	﹤0.01%	1530
2023 Q1	$930K	Sell	19,150 -2,026	-10%	-$92.6K	﹤0.01%	1526
2022 Q4	$813K	Buy	21,176 +11,446	+118%	+$476K	﹤0.01%	1579
2022 Q3	$488K	Buy	9,730 +6,360	+189%	+$312K	﹤0.01%	1682
2022 Q2	$135K	Hold	3,370	–	–	﹤0.01%	1876
2022 Q1	$134K	Hold	3,370	–	–	﹤0.01%	1937
2021 Q4	$134K	Hold	3,370	–	–	﹤0.01%	1949
2021 Q3	$126K	Hold	3,370	–	–	﹤0.01%	2003
2021 Q2	$142K	Sell	3,370 -812	-19%	-$34.8K	﹤0.01%	2012
2021 Q1	$197K	Hold	4,182	–	–	﹤0.01%	1953
2020 Q4	$255K	Hold	4,182	–	–	﹤0.01%	1910
2020 Q3	$195K	Hold	4,182	–	–	﹤0.01%	1908
2020 Q2	$211K	Buy	4,182 +689	+20%	+$33.9K	﹤0.01%	1894
2020 Q1	$157K	Hold	3,493	–	–	﹤0.01%	1874
2019 Q4	$166K	Buy	+3,493	New	+$148K	﹤0.01%	1966
2019 Q3	–	Sell	-5,442	Closed	-$244K	–	1991
2019 Q2	$244K	Sell	5,442 -665	-11%	-$26.3K	﹤0.01%	1977
2019 Q1	$229K	Buy	6,107 +1,527	+33%	+$51.3K	﹤0.01%	1842
2018 Q4	$152K	Hold	4,580	–	–	﹤0.01%	2007
2018 Q3	$215K	Hold	4,580	–	–	﹤0.01%	1960
2018 Q2	$155K	Hold	4,580	–	–	﹤0.01%	2052
2018 Q1	$124K	Hold	4,580	–	–	﹤0.01%	2098
2017 Q4	$76K	Hold	4,580	–	–	﹤0.01%	2254
2017 Q3	$73K	Hold	4,580	–	–	﹤0.01%	2235
2017 Q2	$84K	Hold	4,580	–	–	﹤0.01%	2163
2017 Q1	$45K	Hold	4,580	–	–	﹤0.01%	2333
2016 Q4	$50K	Hold	4,580	–	–	﹤0.01%	2325
2016 Q3	$64K	Hold	4,580	–	–	﹤0.01%	2278
2016 Q2	$32K	Hold	4,580	–	–	﹤0.01%	2410
2016 Q1	$29K	Buy	4,580 +2,480	+118%	+$43K	﹤0.01%	2290
2015 Q4	$68K	Hold	2,100	–	–	﹤0.01%	2008
2015 Q3	$56K	Sell	2,100 -41,700	-95%	-$1.78M	﹤0.01%	2043
2015 Q2	$2.11M	Buy	43,800 +16,700	+62%	+$974K	0.01%	793
2015 Q1	$1.64M	Buy	27,100 +18,700	+223%	+$1.14M	0.01%	835
2014 Q4	$435K	Buy	+8,400	New	+$370K	﹤0.01%	986

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Canada Life's PTCT Position: Q2 2026 in Review

Canada Life reduced its PTC Therapeutics (PTCT) stake by 1.9% in Q2 2026, selling an estimated $91.4K and leaving 64,112 shares worth $5.22M. The position accounts for 0.01% of the portfolio, ranked #770.

Canada Life first reported a position in PTCT in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.94M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Canada Life held 64,112 shares of PTC Therapeutics worth $5.22M as of Q2 2026.
Canada Life sold 1,266 PTC Therapeutics shares in Q2 2026, an estimated $91.4K.
PTC Therapeutics made up 0.01% of Canada Life's portfolio in Q2 2026, its #770 holding.
Canada Life first reported a position in PTC Therapeutics in Q4 2014 and has held it in 46 quarters since.
Canada Life's PTC Therapeutics position peaked at $5.94M in Q4 2025.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.